# Domain Associates

Investor in San Diego, California

## About Domain Associates

Founded in 1985, Domain was one of the first venture capital firms to exclusively invest in the life sciences sector. Domain has been involved in the formation of more than 260 companies. Today, with more than $2.7 billion in capital raised, Domain is a proven healthcare venture capital leader with solid investment returns from companies built to advance human health.

Domain’s primary investment areas are pharmaceuticals, diagnostics, and medical devices. We also evaluate and opportunistically invest in evolving sectors of the life sciences industry, such as healthcare IT, and technologies addressing specific healthcare issues, such as healthcare economics.

Once invested, Domain takes an active role in guiding the growth of the company.

Our strategies include:

▪ Therapeutics and medical devices that are highly differentiable and address medical needs. ▪ Clinical diagnostics that positively impact both quality of care and costs. ▪ Tools and instrumentations that have the potential for a large impact on healthcare. ▪ Healthcare information technologies that better manage care and costs.

## People

- **Jim Blair**, Partner

## Key Facts

- **Location:** San Diego, California
- **Investor Type:** Venture Capital
- **Founded:** 1985

## Investment Industries

- Biotech
- Health and Wellness
- Medical/Healthcare

## How to Contact

Direct messaging and this investor's website are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/domain-associates
- More investors: [Biotech Investors in California](https://askforfunding.com/site/angel-investors/california/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
